关注
Sakineh Pirahmadi
Sakineh Pirahmadi
PhD of medical biotechnology, Pasteur Institue of Iran
在 pasteur.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Genetic variation of TLR-4, TLR-9 and TIRAP genes in Iranian malaria patients
S Zakeri, S Pirahmadi, AA Mehrizi, ND Djadid
Malaria Journal 10, 1-7, 2011
622011
Molecular genetic analysis of Plasmodium vivax isolates from Eastern and Central Sudan using pvcsp and pvmsp-3α genes as molecular markers
AA Talha, S Pirahmadi, AA Mehrizi, ND Djadid, BYM Nour, Z Sedighe
infection genetics and evolution 32, 12-22, 2015
282015
Molecular assessment of atpase6 mutations associated with artemisinin resistance among unexposed and exposed Plasmodium falciparum clinical isolates to …
S Zakeri, S Hemati, S Pirahmadi, M Afsharpad, A Raeisi, ND Djadid
Malaria Journal 11, 1-8, 2012
272012
Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection …
S Pirahmadi, S Zakeri, A A. Mehrizi, N D. Djadid, AA Raz, J J. Sani, ...
Malaria journal 18, 1-16, 2019
262019
Genetic variability of CYP2B6 polymorphisms in southeast Iranian population: implications for malaria and HIV/AIDS treatment
S Zakeri, N Amiri, S Pirahmadi, ND Djadid
Archives of Iranian Medicine 17 (10), 0-0, 2014
242014
Mutation analysis in pfmdr1 and pfmrp1 as potential candidate genes for artemisinin resistance in Plasmodium falciparum clinical isolates 4 years after implementation of …
S Pirahmadi, S Zakeri, M Afsharpad, ND Djadid
Infection, Genetics and Evolution 14, 327-334, 2013
242013
Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine–pyrimethamine plus artesunate as the first line treatment in Iran
M Afsharpad, S Zakeri, S Pirahmadi, ND Djadid
Acta tropica 121 (1), 13-18, 2012
232012
A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development
S Pirahmadi, S Zakeri, ND Djadid, AA Mehrizi
International journal for parasitology 51 (9), 699-717, 2021
202021
Combining monophosphoryl lipid A (MPL), CpG oligodeoxynucleotide (ODN), and QS-21 adjuvants induces strong and persistent functional antibodies and T cell responses against …
S Pirahmadi, S Zakeri, AA Mehrizi, ND Djadid, AA Raz, JJ Sani
Infection and immunity 87 (6), 10.1128/iai. 00911-18, 2019
202019
Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran
M Afsharpad, S Zakeri, S Pirahmadi, ND Djadid
Infection, Genetics and Evolution 12 (1), 38-44, 2012
182012
High prevalence of pfdhfr–pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine …
M Rouhani, S Zakeri, S Pirahmadi, A Raeisi, ND Djadid
Infection, Genetics and Evolution 31, 183-189, 2015
162015
Analysis of genetic diversity and population structure of gene encoding cell-traversal protein for ookinetes and sporozoites (CelTOS) vaccine candidate antigen in global …
S Pirahmadi, S Zakeri, AA Mehrizi, ND Djadid
Infection, Genetics and Evolution 59, 113-125, 2018
152018
How can we develop an effective subunit vaccine to achieve successful malaria eradication?
S Pirahmadi, S Afzali, M Zargar, S Zakeri, AA Mehrizi
Microbial pathogenesis 160, 105203, 2021
102021
CRISPR/Cas advancements for genome editing, diagnosis, therapeutics, and vaccine development for Plasmodium parasites, and genetic engineering of Anopheles mosquito vector
L Nourani, AA Mehrizi, S Pirahmadi, Z Pourhashem, E Asadollahi, ...
Infection, Genetics and Evolution 109, 105419, 2023
92023
Absence of asymptomatic malaria infection in a cross-sectional study in Iranshahr district, Iran under elimination programmes
S Pirahmadi, S Zakeri, A Raeisi
Iranian Journal of Parasitology 12 (1), 90, 2017
92017
Prevalence of mutations in the antifolates resistance-associated genes (dhfr and dhps) in Plasmodium vivax parasites from Eastern and Central Sudan
S Pirahmadi, BA Talha, BYM Nour, S Zakeri
Infection, Genetics and Evolution 26, 153-159, 2014
92014
Multiple genotypes of the commonly co-segregating Toll-like receptor 4 Asp299Gly and Thr399Ile in Baluchi malaria patients from Iran
S Pirahmadi, S Zakeri, AA Mehrizi
Cell Journal (Yakhteh) 15 (2), 182, 2013
92013
Heterogeneity in the acquisition of naturally acquired antibodies to cell-traversal protein for ookinetes and sporozoites (CelTOS) and thrombospondin-related adhesion protein …
S Pirahmadi, S Zakeri, AA Mehrizi, L Karimi, ND Djadid
Acta tropica 190, 365-374, 2019
72019
Low prevalence of Plasmodium vivax-Plasmodium falciparum mixed-infection in patients from central and eastern part of Sudan: implication for case management in Sudan
AA Talha, S Pirahmadi, EM Elgaily, S Zakeri, BYM Nour
International Journal of TROPICAL DISEASE & Health 4 (8), 887-895, 2014
62014
Evaluation of a new fusion antigen, cd loop and HAP2-GCS1 domain (cd-HAP) of Plasmodium falciparum Generative Cell Specific 1 antigen formulated with …
Z Pourhashem, L Nourani, JJ Sani, H Yousefi, S Pirahmadi, M Sabouri, ...
Malaria Journal 22 (1), 374, 2023
22023
系统目前无法执行此操作,请稍后再试。
文章 1–20